PAS
PHVS icon

Point72 Asia (Singapore)’s Pharvaris PHVS Stock Holding History

Point72 Asia (Singapore)’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$25 Sell
1
-368
-100% -$8.16K ﹤0.01% 846
2025
Q2 		$6.49K Buy
+369
New +$5.95K ﹤0.01% 810

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Point72 Asia (Singapore)'s PHVS Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Pharvaris (PHVS) stake by 100% in Q3 2025, selling an estimated $8.16K and leaving 1 share worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #846.

Point72 Asia (Singapore) first reported a position in PHVS in Q2 2025 and has held it in 2 quarters since. The position peaked at $6.49K in Q2 2025. 83 funds tracked by Wall St. Rank hold PHVS as of Q3 2025.

  • Point72 Asia (Singapore) held 1 share of Pharvaris worth $25 as of Q3 2025.
  • Point72 Asia (Singapore) sold 368 Pharvaris shares in Q3 2025, an estimated $8.16K.
  • Pharvaris made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #846 holding.
  • Point72 Asia (Singapore) first reported a position in Pharvaris in Q2 2025 and has held it in 2 quarters since.
  • Point72 Asia (Singapore)'s Pharvaris position peaked at $6.49K in Q2 2025.
  • 83 funds tracked by Wall St. Rank held Pharvaris as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.